you are here: HomeNewsAjanta pharma
ajanta pharma
Jump to
451 Results Found
  • Buy Ajanta Pharma; target of Rs 2030: Motilal Oswal Feb 12, 2021 03:46 PM IST

    Buy Ajanta Pharma; target of Rs 2030: Motilal Oswal

    Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2030 in its research report dated February 02, 2021.

  • Buy Ajanta Pharma; target of Rs 2208: Dolat Capital Market Feb 09, 2021 11:47 PM IST

    Buy Ajanta Pharma; target of Rs 2208: Dolat Capital Market

    Dolat Capital Market is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2208 in its research report dated February 03, 2021.

  • Ajanta Pharma share price jumps 7%, hits 52-week high as Q3 PAT zooms 64% Feb 03, 2021 10:16 AM IST

    Ajanta Pharma share price jumps 7%, hits 52-week high as Q3 PAT zooms 64%

    The drug firm reported a 64 percent rise in its consolidated net profit to Rs 177 crore for the quarter ended December mainly on account of robust sales.

  • Ajanta Pharma Standalone December 2020 Net Sales at Rs 733.16 crore, up 38.19% Y-o-Y Feb 03, 2021 09:11 AM IST

    Ajanta Pharma Standalone December 2020 Net Sales at Rs 733.16 crore, up 38.19% Y-o-Y

  • Ajanta Pharma Q3 net profit up 64% to Rs 177 crore Feb 02, 2021 09:29 PM IST

    Ajanta Pharma Q3 net profit up 64% to Rs 177 crore

    Consolidated revenue from operations of the company stood at Rs 749 crore for the quarter under consideration.

  • Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y Feb 02, 2021 08:44 PM IST

    Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y

  • FII flows showing signs of slowdown, Nifty resistance placed at 14,500: Gaurav Garg of CapitalVia Global Research Jan 10, 2021 11:06 AM IST

    FII flows showing signs of slowdown, Nifty resistance placed at 14,500: Gaurav Garg of CapitalVia Global Research

    Small and midcap stocks have fared better than the blue-chip stocks, broader market indices seem to be supported by the Auto & ancillary, Banking stocks, and Pharmaceutical sectors, says Garg.

  • Buy Ajanta Pharma; target of Rs 1980: Anand Rathi Nov 09, 2020 03:15 PM IST

    Buy Ajanta Pharma; target of Rs 1980: Anand Rathi

    Anand Rathi is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1980 in its research report dated November 05, 2020.

  • Accumulate Ajanta Pharma; target of Rs 1771: Dolat Capital Market Nov 07, 2020 06:51 PM IST

    Accumulate Ajanta Pharma; target of Rs 1771: Dolat Capital Market

    Dolat Capital Market recommended accumulate rating on Ajanta Pharma with a target price of Rs 1771 in its research report dated November 05, 2020.

  • Ajanta Pharma Consolidated September 2020 Net Sales at Rs 715.91 crore, up 11.38% Y-o-Y Nov 04, 2020 11:22 AM IST

    Ajanta Pharma Consolidated September 2020 Net Sales at Rs 715.91 crore, up 11.38% Y-o-Y

  • Ajanta Pharma shares gain 4% on share buyback plans Oct 29, 2020 09:50 AM IST

    Ajanta Pharma shares gain 4% on share buyback plans

    The scrip witnessed spurt in volume by more than 1.05 times and was trading with volumes of 5,665 shares, compared to its five day average of 5,171 shares, an increase of 9.54 percent.

  • Accumulate Ajanta Pharma; target of Rs 1676: Dolat Capital Aug 09, 2020 09:15 PM IST

    Accumulate Ajanta Pharma; target of Rs 1676: Dolat Capital

    Dolat Capital recommended accumulate rating on Ajanta Pharma with a target price of Rs 1676 in its research report dated August 01, 2020.

  • Ajanta Pharma Consolidated June 2020 Net Sales at Rs 668.20 crore, up 9.19% Y-o-Y Jul 31, 2020 09:33 AM IST

    Ajanta Pharma Consolidated June 2020 Net Sales at Rs 668.20 crore, up 9.19% Y-o-Y

  • Ajanta Pharma Standalone June 2020 Net Sales at Rs 560.85 crore, up 2.77% Y-o-Y Jul 31, 2020 09:33 AM IST

    Ajanta Pharma Standalone June 2020 Net Sales at Rs 560.85 crore, up 2.77% Y-o-Y

  • Ajanta Pharma Q1 profit up 29% at Rs 148 crore Jul 30, 2020 04:35 PM IST

    Ajanta Pharma Q1 profit up 29% at Rs 148 crore

    Total export sales in the quarter were at Rs 483 crore as against Rs 404 crore in the year-ago period, registering a growth of 19 per cent, the company said.

  • Buy Ajanta Pharma; target of Rs 1700: Motilal Oswal May 21, 2020 08:26 PM IST

    Buy Ajanta Pharma; target of Rs 1700: Motilal Oswal

    Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated May 20, 2020.

  • Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results May 21, 2020 06:23 PM IST

    Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results

    The brokerage expects 17 percent earnings CAGR over FY20-22 for Ajanta Pharma.

  • Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y May 21, 2020 09:13 AM IST

    Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y

  • Ajanta Pharma Q4 net profit up 45% to Rs 129 crore May 20, 2020 06:16 PM IST

    Ajanta Pharma Q4 net profit up 45% to Rs 129 crore

    Consolidated revenue from operations of the stood at Rs 682 crore for the quarter under consideration as against Rs 515 crore for the corresponding period a year ago.

  • Ajanta Pharma share price jumps 8% on US FDA nod for cholesterol drug Apr 09, 2020 09:59 AM IST

    Ajanta Pharma share price jumps 8% on US FDA nod for cholesterol drug

    Ajanta Pharma received US FDA nod for Cholestyramine Powder. It is used to lower high levels of cholesterol in blood.

  • Ajanta Pharma Consolidated December 2019 Net Sales at Rs 651.21 crore, up 34.24% Y-o-Y Feb 07, 2020 11:44 AM IST

    Ajanta Pharma Consolidated December 2019 Net Sales at Rs 651.21 crore, up 34.24% Y-o-Y

  • Ajanta Pharma Consolidated December 2019 Net Sales at Rs 651.21 crore, up 34.24% Y-o-Y Feb 06, 2020 11:40 AM IST

    Ajanta Pharma Consolidated December 2019 Net Sales at Rs 651.21 crore, up 34.24% Y-o-Y

  • Ajanta Pharma Standalone September 2019 Net Sales at Rs 559.45 crore, up 20.24% Y-o-Y Nov 06, 2019 09:05 AM IST

    Ajanta Pharma Standalone September 2019 Net Sales at Rs 559.45 crore, up 20.24% Y-o-Y

  • Ajanta Pharma Consolidated September 2019 Net Sales at Rs 642.76 crore, up 18.13% Y-o-Y Nov 06, 2019 09:02 AM IST

    Ajanta Pharma Consolidated September 2019 Net Sales at Rs 642.76 crore, up 18.13% Y-o-Y

  • Ajanta Pharma Consolidated June 2019 Net Sales at Rs 611.94 crore, up 19.76% Y-o-Y Jul 31, 2019 05:52 PM IST

    Ajanta Pharma Consolidated June 2019 Net Sales at Rs 611.94 crore, up 19.76% Y-o-Y

Sections